John I Nwogu MD

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine

Physician

901 leighton Avenue702Anniston, AL 36207
Phone+1 256-231-2577
Fax+1 256-231-2578

Dr. Nwogu is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nwogu's full profile Already have an account?

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Cardiovascular Disease, 1997 - 2000
State University of New York Health Science Center1995 - 1997
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1994 - 1997
State University of New York Health Science Center1994 - 1995
University of Nigeria Teaching HospitalRotational Internship, 1991 - 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1997 - 2029
AL State Medical License 2003 - 2026
VA State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of PhebologyPhlebology
Comprehensive EchocardiographyNational Bpard of Echocardiography
Endovascular MedicineAmerican Board of Vascular Medicine
Nuclear CardiologyCertification Board of Nuclear Cardiology
Vascular MedicineAmerican Board of Vascular Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
American Medical Association (AMA) Physician Recognition Award for Continued Medical Education 2000
Recognition Award for Significant Contribution to the Essentials of Clinical Medicine Course 3-4 College of Medicine, University of Illinois at Chicago, 2000

Publications & Presentations

PubMed

113 citations
Inhibition of Collagen Synthesis With Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation After Myo...
John I. Nwogu, David L. Geenen, Maurice Bean, Mitchell C. Brenner, Xinfan Huang
Circulation. 2001-10-30
31 citations
Is the technically limited echocardiographic study an endangered species? endocardial border definition with native tissue harmonic imaging and Optison contrast: a rev...
Vinay Malhotra, John I. Nwogu, Mary Bondmass, Maurice Bean, Teresa Bieniarz
Journal of the American Society of Echocardiography. 2000-08-01

Journal Articles

Is the Technically Limited Echo Study an Endangered Species? Endocardial Border Definition With Native Tissue Harmonic Imaging and Optison Contrast: A Review of 200...
Vinay Malhotra, John Nwogu, Kathie Dean, Kim Weiss, Maurice Bean, Teresa Bieniarz, Larrisa Brodsky, Meg Tertell, Maureen Conliss, Stephen Devries, J AM Soc Echocardiogr

Abstracts/Posters

Comparison of the Effects of Lisinopril and a Proly 4-Hydroxylase Inhibitor (FG041) on Left Ventricular Function After Acute Myocardial Infarction.
John I Nwogu, Maurice Bean, David L Geenen, Jayant Bagai, Ajanta De, Beth E. Reed, Mehdi Nafissi, Mitchell Brenner and Peter M. Buttrick, University of Illinois at Chicago, Illinois and Fibrogen Inc, South San Francisco California
Inhibition of myocardial fibrosis improves survival and prevents the progression of heart failure after myocardial infarction.
John I Nwogu, MD, Maurice Bean BS, David Geenen PhD, Ajanta De, MD Mitchell Brenner PhD*, and Peter Buttrick, MD, 73rd American Heart Association Annual Scientific Meeting, New Orleans
Inhibition of Collagen Synthesis with Prolyl 4 Hydroxylase (FG041) Improves Left Ventricular Function and Decreases Left Ventricular Dilatation after Myocardial In...
John Nwogu, MD, David Geenen PhD, Maurice Bean BS, Mitchell Brenner PhD*, Xinfan Huang MD*, Peter Buttrick, MD, Annual Chicago Cardiology Scientific Meeting

Other

Aggressive Lipid Therapy.
John Nwogu, MD, Primary Care Physicians in Richmond
Atrial Fibrillation: Strategies for rate control, anticoagulation and Cardioversion.
John Nwogu, MD, Section of Cardiology, University of Illinois at Chicago
Transgenic Models of Cardiac Disease.
John Nwogu, MD, 19th 2000 at Section of Cardiology, University of Illinois at Chicago